Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Artificial Intelligence in Biotechnology Market to Hit USD 7.75 Billion by 2029 with 19.1% CAGR | MarketsandMarkets™


News provided by

MarketsandMarkets

28 Oct, 2024, 14:30 GMT

Share this article

Share toX

Share this article

Share toX

DELRAY BEACH, Fla., Oct. 28, 2024 /PRNewswire/ -- The global AI in Biotechnology market is projected to reach USD 7.75 billion by 2029 from USD 3.23 billion in 2024, at a high CAGR of 19.1% during the forecast period. Increasing cross-industry collaborations and partnerships that foster innovation and resource sharing are the main reasons for the growth of this market. High penetration of AI-powered biomarker discovery for complex diseases, rising utilization of AI in digital twins for drug discovery, and AI and CRISPR-Cas9 synergy in genetic drug discovery are some of the other factors propelling market growth. However, several factors will likely restrain market growth such as fragmented global regulations for AI, lack of sufficient AI infrastructure in developing economies, and difficulties in applying ai-generated knowledge to clinical settings are some factors contributing to challenges in the market growth.

This image opens in the lightbox
MarketsandMarkets Logo

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=91793150

Browse in-depth TOC on "Artificial Intelligence in Biotechnology Market"

200 - Tables
50 - Figures
300 - Pages

Based on deployment mode, the AI in biotechnology market is categorized into cloud-based and on-premises. The cloud-based segment accounted for the largest share of AI in biotechnology market in 2023. Each deployment type offers distinct advantages and is chosen based on factors like data sensitivity, scalability, cost considerations, and operational flexibility. cloud-based solutions offer scalability, ease of access, and reduced upfront costs, allowing companies to rapidly expand their AI capabilities without heavy investment in hardware. In contrast, on-premises deployments provide greater control over data security and infrastructure, making them ideal for organizations handling sensitive research and patient information.

Based on end user, the research institutes and labs segment are expected to register the fastest growth in the AI in biotechnology market. A significant share of this segment is attributed to the growing need to analyse enormous amounts of data and uncover meaningful patterns and insights that exceed human capacity, as human analysts often struggle to keep up with the volume and complexity. Also, AI enables researchers to create virtual models of complex biological processes that are difficult to replicate in real-life lab settings. This capability helps scientists explore different experimental conditions and predict outcomes without the need for physical experiments and the integration of AI can help researchers to be more effective and make informed decisions, saving time and resources.

North America holds the largest share of the AI in biotechnology market in 2023 followed by Europe and the Asia Pacific, by region. Drivers include substantial funding for AI-based startups and research projects for the development and deployment of AI solutions within the biotechnology sector, and the growing need to find causes of problems in diagnostic research also, wide range of sectors integrating AI into their solutions and operations, which is increasing overall market demand.

Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=91793150

Prominent players in the AI in the biotechnology market include NVIDIA Corporation (US), Illumina, Inc. (US), Exscientia plc (UK), Schrödinger, Inc. (US), Recursion Pharmaceuticals, Inc.  (US), SOPHiA GENETICS (Switzerland), Predictive Oncology. (US), Deep Genomics. (Canada), Data4Cure, Inc. (US), Genoox (US), BenevolentAI (US), DNAnexus, Inc. (US), Tempus (US), NuMedii, Inc. (US), XtalPi Inc. (US), Lifebit Biotech Ltd (England), BPGbio, Inc. (US), Valo Health (US), VeriSIM Life. (US), Iktos.   (France), Insilico Medicine (US), Eurofins Discovery. (US), Logica. (US), American Chemical Society (US), Aganitha AI Inc. (India).

These companies adopted strategies such as partnerships, collaborations, acquisitions, expansion, agreements, investment, and product launches to strengthen their market presence in the AI in Biotechnology market. 

NVIDIA Corporation engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. Initially, the firm was primarily operating in graphics hardware for gaming, but through time, over the recent years, NVIDIA has been more focused towards applications of AI, machine learning, deep learning, and data science in a wide array of industries as well as into healthcare, for example. The company's GPUs have been known to provide better performance in AI computing; it thus formed the core of moving research that is driven by AI, including applications in medical imaging and digital pathology. NVIDIA is making deep inroads in the healthcare sector by furthering the development of AI innovations using its NVIDIA Clara platform as an AI engine that offers AI tools and frameworks for medical imaging, genomics, and drug discovery. At the level of digital pathology, NVIDIA is utilizing GPUs and AI frameworks to facilitate accelerated image analysis and faster and more accurate diagnosis from pathology slides. The company operates in North America, South America, Asia Pacific, and Europe.

Illumina, Inc. is one of the leading providers of genomic solutions. The company delivers array-based life sciences technology and DNA sequencing to facilitate personalized health and advanced research & discovery. It offers products related to infectious diseases, genetics, reproductive health oncology, and others. Illumina has collaborated with several global payers such as AstraZeneca, Janssen, PRECISE, Bristol-Myers Squibb, Kura Oncology, Myriad Genetics, Merck, and others to expand their product portfolio and strengthen their position in the global market.

Exscientia plc is a drug design firm that effectively develops medications for illnesses with substantial unmet patient needs by utilizing artificial intelligence (AI) and innovative technologies. The company aims to improve the probability of successful medication development by identifying and addressing potential causes of failure in the drug design process. Exscientia's technological platform includes several innovative methods, including generative Al, active learning, machine learning, and physics-based systems.

For more information, Inquire Now!

Related Reports:

Home Healthcare Market

Clinical Trials Market

Biomarkers Market

Artificial Intelligence in Medical Diagnostics Market

Artificial Intelligence in Genomics Market

Get access to the latest updates on Al in Biotechnology Companies and Al in Biotechnology Market Share

About MarketsandMarkets™:

MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/

Logo: https://mma.prnewswire.com/media/1951202/4609423/MarketsandMarkets.jpg

Modal title

Also from this source

Chromatography Accessories & Consumables Market worth US$8.74 billion by 2030 with 7.5% CAGR | MarketsandMarkets™

Chromatography Accessories & Consumables Market worth US$8.74 billion by 2030 with 7.5% CAGR | MarketsandMarkets™

The global Chromatography Accessories & Consumables Market, valued at US$4.79 billion in 2023, is forecasted to grow at a robust CAGR of 7.5%,...

Smart Railways Market worth $54.31 billion by 2030- Exclusive Report by MarketsandMarkets™

Smart Railways Market worth $54.31 billion by 2030- Exclusive Report by MarketsandMarkets™

The Smart Railways Market is estimated to be USD 36.49 billion in 2025 and is projected to reach USD 54.31 billion by 2030, registering a CAGR of...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Artificial Intelligence

Artificial Intelligence

Biotechnology

Biotechnology

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.